These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10833839)

  • 21. [Enoxaparin (Clexane), a low molecular weight heparin in preventing thrombosis].
    Jørgensen LN; Hauch O
    Ugeskr Laeger; 1989 Nov; 151(48):3256-8. PubMed ID: 2556826
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of low molecular weight heparin (Clexane) together with selective COX-2 inhibitor (Dynastat--once or twice per day)].
    Tablov B; Ruseva A; Tablov V; Popov I; Stoĭkov S
    Akush Ginekol (Sofiia); 2005; 44(5):31-4. PubMed ID: 16313051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood coagulation: hemostasis and thrombin regulation.
    Tanaka KA; Key NS; Levy JH
    Anesth Analg; 2009 May; 108(5):1433-46. PubMed ID: 19372317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Defibrotide versus heparin in antithrombotic prophylaxis in gynecological surgery].
    Lippi G; Viliani T; Alessandrello-Liotta A; Morelli P; Zucconi G; Doni A; Gerosa C
    Minerva Med; 1989 May; 80(5):455-9. PubMed ID: 2664571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Locoregional spinal anesthesia and hemostasis: fewer problems, more solutions].
    Samama CM
    Rev Esp Anestesiol Reanim; 2005; 52(7):382. PubMed ID: 16200916
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative analysis of arterial bioprostheses with various antithrombotic modification].
    Barbarash LS; Burkov NN; Kudriavtseva IuA; Anufriev AI; Zhuravleva IIu
    Angiol Sosud Khir; 2012; 18(2):21-5. PubMed ID: 22929666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
    Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
    Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The heparin prophylaxis of gas exchange disorders in disseminated intravascular blood coagulation].
    Riabov GA; Pasechnik IN; Emtsov IuG
    Ter Arkh; 1991; 63(7):74-7. PubMed ID: 1788815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complication with paraaortic lymphadenectomy in gynecological cancer patients].
    Miyazaki K; Mizuno K; Hirokawa W; Hiromura K; Hori K; Minami K; Yoshida K; Takeuchi M; Suzuki S; Kuno N; Ando T; Furuhashi M; Ishikawa K
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1439-42. PubMed ID: 17876142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical application of enoxaparin.
    Hofmann T
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):321-37. PubMed ID: 15151480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of postoperative thrombotic complications by a combination of small doses of heparin and digitamin in oncologic patients].
    Maslikhova VN; Madzhuga AV; Pavlova ZV; Zaĭtseva TI; Somonova OV
    Ross Med Zh; 1992; (3):39-41. PubMed ID: 1643359
    [No Abstract]   [Full Text] [Related]  

  • 35. [Administration of clexane 4000 U/0.4 ml (40 mg) for preventing venous thromboembolic complications in patients undergoing surgery for malignant tumors. A follow-up study].
    Farkas E; Péley G; Mátrai Z; Rényi-Vámos F; Köves I
    Magy Seb; 2005 Jun; 58(3):197-200. PubMed ID: 16167477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Indications and clinical application of thrombosis prophylaxis. I].
    Mittelkötter U; Reith HB; Thiede A
    Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
    [No Abstract]   [Full Text] [Related]  

  • 37. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparin-induced thrombocytopenia in patients and prevention with low molecular weight heparin].
    Kormanová K; Krska Z; Trca S; Pesková M; Korínková P
    Sb Lek; 2001; 102(3):419-25. PubMed ID: 12092129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discoveries in thrombosis care for medical patients.
    Cohen AT
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():13-7. PubMed ID: 12232818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of deep vein thrombosis with enoxaparin in pediatric cancer patients receiving chemotherapy.
    Stine KC; Saylors RL; Saccente CS; Becton DL
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):161-5. PubMed ID: 17456625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.